The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Claus Rödel

Department of Radiation Oncology

University of Erlangen-Nürnberg

Erlangen

Germany

[email]@*.med.uni-erlangen.de

Name/email consistency: high

 
 
 
 
 
 
 

Affiliation

  • Department of Radiation Oncology, University of Erlangen-Nürnberg, Erlangen, Germany. 2000 - 2007

References

  1. Multicenter phase II trial of chemoradiation with oxaliplatin for rectal cancer. Rödel, C., Liersch, T., Hermann, R.M., Arnold, D., Reese, T., Hipp, M., Fürst, A., Schwella, N., Bieker, M., Hellmich, G., Ewald, H., Haier, J., Lordick, F., Flentje, M., Sülberg, H., Hohenberger, W., Sauer, R. J. Clin. Oncol. (2007) [Pubmed]
  2. Trimodality treatment and selective organ preservation for bladder cancer. Rödel, C., Weiss, C., Sauer, R. J. Clin. Oncol. (2006) [Pubmed]
  3. Organ preservation by combined modality treatment in bladder cancer: the European perspective. Rödel, C., Weiss, C., Sauer, R. Semin. Radiat. Oncol (2005) [Pubmed]
  4. Neoadjuvant radiotherapy and radiochemotherapy for rectal cancer. Rödel, C., Sauer, R. Recent Results Cancer Res. (2005) [Pubmed]
  5. Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer. Rödel, C., Martus, P., Papadoupolos, T., Füzesi, L., Klimpfinger, M., Fietkau, R., Liersch, T., Hohenberger, W., Raab, R., Sauer, R., Wittekind, C. J. Clin. Oncol. (2005) [Pubmed]
  6. What is the role of radiotherapy in bladder-preserving cancer therapy?. Rödel, C., Sauer, R. Nature Clinical Practice. Oncology (2005) [Pubmed]
  7. Neoadjuvant radiochemotherapy in rectal cancer: for which patients and tumor stages?. Rödel, C., Sauer, R. Front. Radiat. Ther. Oncol (2004) [Pubmed]
  8. Current status of radiation therapy and combined-modality treatment for bladder cancer. Rödel, C. Strahlenther. Onkol (2004) [Pubmed]
  9. Radiotherapy and concurrent radiochemotherapy for rectal cancer. Rödel, C., Sauer, R. Surg. Oncol (2004) [Pubmed]
  10. Spontaneous and radiation-induced apoptosis in colorectal carcinoma cells with different intrinsic radiosensitivities: survivin as a radioresistance factor. Rödel, C., Haas, J., Groth, A., Grabenbauer, G.G., Sauer, R., Rödel, F. Int. J. Radiat. Oncol. Biol. Phys. (2003) [Pubmed]
  11. Phase I/II trial of capecitabine, oxaliplatin, and radiation for rectal cancer. Rödel, C., Grabenbauer, G.G., Papadopoulos, T., Hohenberger, W., Schmoll, H.J., Sauer, R. J. Clin. Oncol. (2003) [Pubmed]
  12. Invasive bladder cancer: organ preservation by radiochemotherapy. Rödel, C., Grabenbauer, G.G., Kühn, R., Dunst, J., Papadopoulos, T., Schrott, K.M., Sauer, R. Front. Radiat. Ther. Oncol (2002) [Pubmed]
  13. Apoptosis as a cellular predictor for histopathologic response to neoadjuvant radiochemotherapy in patients with rectal cancer. Rödel, C., Grabenbauer, G.G., Papadopoulos, T., Bigalke, M., Günther, K., Schick, C., Peters, A., Sauer, R., Rödel, F. Int. J. Radiat. Oncol. Biol. Phys. (2002) [Pubmed]
  14. Organ preservation in patients with invasive bladder cancer: initial results of an intensified protocol of transurethral surgery and radiation therapy plus concurrent cisplatin and 5-fluorouracil. Rödel, C., Grabenbauer, G.G., Kühn, R., Zörcher, T., Papadopoulos, T., Dunst, J., Schrott, K.M., Sauer, R. Int. J. Radiat. Oncol. Biol. Phys. (2002) [Pubmed]
  15. Combined-modality treatment and selective organ preservation in invasive bladder cancer: long-term results. Rödel, C., Grabenbauer, G.G., Kühn, R., Papadopoulos, T., Dunst, J., Meyer, M., Schrott, K.M., Sauer, R. J. Clin. Oncol. (2002) [Pubmed]
  16. Radiotherapy is an effective treatment for high-risk T1-bladder cancer. Rödel, C., Dunst, J., Grabenbauer, G.G., Kühn, R., Papadopoulos, T., Schrott, K.M., Sauer, R. Strahlenther. Onkol (2001) [Pubmed]
  17. Apoptosis, p53, bcl-2, and Ki-67 in invasive bladder carcinoma: possible predictors for response to radiochemotherapy and successful bladder preservation. Rödel, C., Grabenbauer, G.G., Rödel, F., Birkenhake, S., Kühn, R., Martus, P., Zörcher, T., Fürsich, D., Papadopoulos, T., Dunst, J., Schrott, K.M., Sauer, R. Int. J. Radiat. Oncol. Biol. Phys. (2000) [Pubmed]
  18. Preoperative radiation with concurrent 5-fluorouracil for locally advanced T4-primary rectal cancer. Rödel, C., Grabenbauer, G.G., Schick, C., Papadopoulos, T., Hohenberger, W., Sauer, R. Strahlenther. Onkol (2000) [Pubmed]
 
WikiGenes - Universities